|
Cx43 expression and invasive capacity of gliomas maintained in nude mice |
||||||
| Controls |
CBX |
|||||
|
|
|
|||||
| Tumor |
Tumor§ |
Cx43 |
(S-S0)/S0 |
Cells/mm perimeter |
(S-S0)/S0 |
Cells/mm perimeter |
|
|
||||||
| T1 |
TG-4-GEN |
+++ |
1.15 ± 0.23 |
77 ± 9.4 |
1.05 ± 0.11 |
68 ± 5.6 |
| T2 |
TG-1-HAM |
+++ |
0.56 ± 0.05 |
81 ± 9.4 |
0.29 ± 0.08 *** |
50 ± 7.5 * |
| T3 |
TG-7-ROM |
+ |
0a |
- |
0a |
- |
| T4 |
TG-14-RAV |
+++ |
1.11 ± 0.08 |
73 ± 6.7 |
0.71 ± 0.04 ** |
54 ± 4.7 * |
| T6 |
TG-5-RAI |
+/- |
0a |
- |
0a |
- |
| T7 |
TG-14-CHA |
+++ |
0.45 ± 0.08 |
48 ± 4.2 |
0.22 ± 0.01 *** |
35 ± 4.4 * |
| T8 |
TG-20-THO |
+/- |
0a |
- |
0a |
- |
|
a, cut off : a tumor which exhibited less than 15 migrating cells distance of migration, if any, less than 50 μm, was considered non invasive. § Xenograft tumor nomenclature as originally described by Leuraud et al (2003). n = 7–10 per group and condition. ***, p < 0.001. **, p < 0.01, *, p < 0.05 | ||||||
Oliveira et al. BMC Cell Biology 2005 6:7 doi:10.1186/1471-2121-6-7 |
||||||